Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 623

Results For "AI"

6967 News Found

Ayushman Bharat PM-JAY rates revised
Public Health | October 06, 2021

Ayushman Bharat PM-JAY rates revised

The rates for over 400 procedures were revised


Boston Scientific to acquire Baylis Medical Company for US $ 1.75 billion
Medical Device | October 06, 2021

Boston Scientific to acquire Baylis Medical Company for US $ 1.75 billion

The transaction is anticipated to close in the first quarter of 2022


Pradhan Mantri Bhartiya Janaushadhi Pariyojana stores open in all  districts
Public Health | October 06, 2021

Pradhan Mantri Bhartiya Janaushadhi Pariyojana stores open in all districts

A total of 8308 stores are open across India and medicines are priced at affordable rates


Apollo Hospitals launches Centre of Excellence in Critical Care
Hospitals | October 06, 2021

Apollo Hospitals launches Centre of Excellence in Critical Care

The initiative will create an integrated network of Critical Care Units (CCUs) across the Apollo Hospitals network but also in partnership with non-Apollo units in India and overseas


Temasek to buy a stake in Integrace
Startup | October 05, 2021

Temasek to buy a stake in Integrace

The company claims to be a market leader in core orthopaedic and gynaecology segments like bone and joint disorders, pain management and, pregnancy and women’s nutrition


Health ministry’s eSanjeevani completes 1.3 crore consultations
Public Health | October 05, 2021

Health ministry’s eSanjeevani completes 1.3 crore consultations

More than 90,000 patients utilise the services daily


Health minister Mandaviya launches i-Drone for vaccine delivery
Public Health | October 05, 2021

Health minister Mandaviya launches i-Drone for vaccine delivery

This is the first time in South Asia an indigenously made drone was used to transport Covid-19 vaccines


AstraZeneca requests Emergency Use Authorisation for drug to prevent Covid
Biotech | October 05, 2021

AstraZeneca requests Emergency Use Authorisation for drug to prevent Covid

The filing includes data from PROVENT Phase III trial showing 77% reduction in risk of developing symptomatic Covid-19 with a long-acting antibody combination (non-vaccine)


Mawi DNA announce partnership with FUJIFILM
Medical Device | October 05, 2021

Mawi DNA announce partnership with FUJIFILM

FUJIFILM will distribute iSWAB bio sampling technologies in Japan


Amber Implants VCFix spinal system receives breakthrough designation
Healthcare | October 05, 2021

Amber Implants VCFix spinal system receives breakthrough designation

The first clinical trial is expected to commence in early 2022 both in Europe and the US